SOPHiA GENETICS: aMoon Edge sells about $1.48M
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SOPHiA GENETICS SA ordinary shares were the subject of aMoon Edge Limited Partnership’s private block sale of 192,541 shares on November 10, 2026, at $7.70 per share. The sale generated gross proceeds of approximately $1.48 million.
Separately, aMoon Growth Fund Limited Partnership reported holding 5,318,023 ordinary shares, approximately 6.2% of the issued and outstanding ordinary shares, excluding treasury shares. The reported percentage uses 85,658,321 shares outstanding as of September 30, 2026. The filing states that aMoon Growth G.P. Limited Partnership, aMoon General Partner Ltd., and Director Dr. Yair C. Schindel may be deemed to share voting and investment power over aMoon Growth’s shares; Schindel disclaimed beneficial ownership except to the extent of any pecuniary interest.
Filing Explained
After the disclosed sale, aMoon Edge and its general partner report zero beneficial ownership of SOPHiA GENETICS shares; this is a seller-level exit, separate from the continuing stake reported for aMoon Growth.
Key Figures
Key Terms
private block sale financial
pecuniary interest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.